SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Geriatric Psychiatry and Neurology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Aarsland, D.
Right arrow Articles by Halliday, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aarsland, D.
Right arrow Articles by Halliday, G.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Are Parkinson’s Disease with dementia and Dementia with lewy Bodies the Same Entity?

Dag Aarsland, MD, PhD

Centre for Neuro and Geriatric Psychiatric Research, Psychiatric Clinic, Rogaland Central Hospital, PO Box 1163, Hillevaag, 4095 Stavanger, Norwaydaa{at}sir.no

C. G. Ballard, MD, MRCPsych

Institute of Psychiatry, King’s College London, United Kingdom

Glenda Halliday, PhD

Prince of Wales Medical Research Institute and the University of New South Wales, Sydney, Australia

The diagnosis of Parkinson’s disease with dementia (PDD) or dementia with Lewy bodies (DLB) is based on an arbitary distinction between the time of onset of motor and cognitive symptoms. These syndromes share many neurobiological similarities, but there are also differences. Deposition of beta-amyloid protein is more marked and more closely related to cognitive impairment in DLB than PDD, possibly contributing to dementia at onset. The relatively more severe executive impairment in DLB than PDD may relate to the loss of frontohippocampal projections in DLB. Visual hallucinations and delusions associate with more abundant Lewy body pathology in temporal cortex in DLB. The differential involvement of pathology in the striatum may account for the differences in parkinsonism. Longitudinal studies with neuropathological and neurochemical evaluations will be essential to enable more robust comparisons and determine pathological substrates contributing to the differences in cognitive, motor, and psychiatric symptoms. (J Geriatr Psychiatry Neurol 2004; 17:137-145)

Key Words: cognition • dementia • Lewy bodies • neurochemistry • neuropathology • parkinsonism

References

  • 1. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47:1113-1124.[Abstract/Free Full Text]
  • 2. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60:387-392.[Abstract/Free Full Text]
  • 3. Burton EJ, McKeith IG, Burn DJ, Williams ED, O’Brien JT. Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain 2004; 127(pt 4):791-800.[Abstract/Free Full Text]
  • 4. Double KL, Halliday GM, McRitchie DA, Reid WG, Hely MA, Morris JG. Regional brain atrophy in idiopathic Parkinson’s disease and diffuse Lewy body disease. Dementia 1996; 7:304-313.
  • 5. Harvey GT, Hughes J, McKeith IG, et al. Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer’s disease: a pilot study. Psychol Med 1999; 29:181-187.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 6. Cordato NJ, Halliday GM, Harding AJ, Hely MA, Morris JG. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann Neurol 2000; 47:718-728.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 7. Barber R, McKeith I, Ballard C, O’Brien J. Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer’s disease, and vascular dementia. J Neurol Neurosurg Psychiatry 2002; 72:406-407.[Abstract/Free Full Text]
  • 8. Cousins DA, Burton EJ, Burn D, Gholkar A, McKeith IG, O’Brien JT. Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease: an MRI study. Neurology 2003; 61:1191-1195.[Abstract/Free Full Text]
  • 9. Barber R, McKeith IG, Ballard C, Gholkar A, O’Brien JT. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer’s disease: magnetic resonance imaging volumetric study. Dement Geriatr Cogn Disord 2001; 12:198-205.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 10. Gomez-Isla T, Growdon WB, McNamara M, et al. Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies. Neurology 1999; 53:2003-2009.[Abstract/Free Full Text]
  • 11. Broe M, Shepherd CE, Milward EA, Halliday GM. Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer’s disease and dementia with Lewy bodies. Acta Neuropathol (Berl) 2001; 101:616-624.[Medline] [Order article via Infotrieve]
  • 12. Shepherd CE, McCann H, Thiel E, Halliday GM. Neurofilament-immunoreactive neurons in Alzheimer’s disease and dementia with Lewy bodies. Neurobiol Dis 2002; 9:249-257.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 13. Harding AJ, Lakay B, Halliday GM. Selective hippocampal neuron loss in dementia with Lewy bodies. Ann Neurol 2002; 51:125-128.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 14. Harding AJ, Halliday GM. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol (Berl) 2001; 102:355-363.[Medline] [Order article via Infotrieve]
  • 15. Colosimo C, Hughes AJ, Kilford L, Lees AJ. Lewy body cortical involvement may not always predict dementia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2003; 74:852-856.[Abstract/Free Full Text]
  • 16. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 2002; 59:102-112.[Abstract/Free Full Text]
  • 17. Richard IH, Papka M, Rubio A, Kurlan R. Parkinson’s disease and dementia with Lewy bodies: one disease or two? Mov Disord 2002; 17:1161-1165.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 18. Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002; 125:391-403.[Abstract/Free Full Text]
  • 19. Samuel W, Galasko D, Masliah E, Hansen LA. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer’s disease. J Neuropathol Exp Neurol 1996; 55:44-52.[Web of Science][Medline] [Order article via Infotrieve]
  • 20. Kovari E, Gold G, Herrmann FR, et al. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson’s disease. Acta Neuropathol (Berl) 2003; 106:83-88.[Medline] [Order article via Infotrieve]
  • 21. Mastaglia FL, Johnsen RD, Byrnes ML, Kakulas BA. Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson’s disease. Mov Disord 2003; 18:81-86.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 22. Jellinger KA, Seppi K, Wenning GK, Poewe W. Impact of coexistent Alzheimer pathology on the natural history of Parkinson’s disease. J Neural Transm 2002; 109:329-339.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 23. Piggott MA, Marshall EF, Thomas N, et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer’s and Parkinson’s diseases: rostrocaudal distribution. Brain 1999; 122(pt 8):1449-1468.[Abstract/Free Full Text]
  • 24. O’Brien JT, Colloby SJ, Aarsland D, et al. Dopamine transporter loss visualised with PF-CIT SPECT in dementia with Lewy bodies. Arch Neurol In press.
  • 25. Ransmayrl G, Seppi K, Donnemiller E, et al. Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson’s disease. Eur J Nucl Med 2001; 28:1523-1528.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 26. Halliday GM, McRitchie DA, Cartwright H, Pamphlett R, Hely MA, Morris JG. Midbrain neuropathology in idiopathic Parkinson’s disease and diffuse Lewy body disease. J Clin Neurosci 1996; 3:52-60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 27. Duda JE, Giasson BI, Mabon ME, Lee VM, Trojanowski JQ. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 2002; 52:205-210.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 28. Duda JE. Pathology and neurotransmitter abnormalities of dementia with Lewy bodies. Dement Geriatr Cogn Disord 2004; 17(suppl 1):3-14.
  • 29. Piggott MA, Owens J, O’Brien J, et al. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease. J Chem Neuroanat 2003; 25:161-173.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 30. Suzuki M, Desmond TJ, Albin RL, Frey KA. Striatal monoaminergic terminals in Lewy body and Alzheimer’s dementias. Ann Neurol 2002; 51:767-771.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 31. Tiraboschi R, Hansen LA, Alford M, et al. Cholinergic dys-function in diseases with Lewy bodies. Neurology 2000; 54:407-411.[Abstract/Free Full Text]
  • 32. Ziabreva I, Ballard CG, Aarsland D, Larsen JP, Perry EK. Cortical and thalamic cholinergic activity in Lewy body disease in relation to dementia and parkinsonism. Paper presented at: 8th International Congress of Parkinson’s Disease and Movement Disorders; June 13-17, 2004; Rome, Italy.
  • 33. Lippa CF, Smith TW, Perry E. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology. J Neural Transm 1999; 106:525-535.
  • 34. Perry EK, Curtis M, Dick DJ, et al. Cholinergic correlates of cognitive impairment in Parkinson’s disease: comparisons with Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1985; 48:413-421.[Abstract/Free Full Text]
  • 35. Court JA, Piggott MA, Lloyd S, et al. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease and in relation to neuroleptic medication. Neuroscience 2000; 98:79-87.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 36. Aubert I, Araujo DM, Cecyre D, Robitaille Y, Gauthier S, Quirion R. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer’s and Parkinson’s diseases. J Neurochem 1992; 58:529-541.[Web of Science][Medline] [Order article via Infotrieve]
  • 37. Ballard C, Piggott M, Johnson M, et al. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol 2000; 48:868-876.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 38. Perry EK, Irving D, Kerwin JM, et al. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson’s and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord 1993; 7:69-79.[Web of Science][Medline] [Order article via Infotrieve]
  • 39. Pimlott SL, Piggott M, Owens J, et al. Nicotinic acetylcholine receptor distribution in Alzheimer’s disease, dementia with Lewy bodies, Parkinson’s disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380. Neuropsycho-pharmacology 2004; 29:108-116.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 40. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 1997; 276:2045-2047.[Abstract/Free Full Text]
  • 41. Hardy J. The relationship between Lewy body disease, Parkinson’s disease, and Alzheimer’s disease. Ann N Y Acad Sci 2003; 991:167-170.[Web of Science][Medline] [Order article via Infotrieve]
  • 42. Singleton AB, Farrer M, Johnson J, et al. Alpha-synuclein locus triplication causes Parkinson’s disease. Science 2003; 302:841-841.[Free Full Text]
  • 43. Tsuang DW, Dalan AM, Eugenio CJ, et al. Familial dementia with Lewy bodies: a clinical and neuropathological study of 2 families. Arch Neurol 2002; 59:1622-1630.[Abstract/Free Full Text]
  • 44. Harding AJ, Das A, Kril JJ, Brooks WS, Duffy D, Halliday GM. Identification of families with cortical Lewy body disease. Am J Med Genet In press.
  • 45. Singleton AB, Wharton A, O’Brien KK, et al. Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2002; 14:167-175.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 46. Parsian A, Racette B, Goldsmith LJ, Perlmutter JS. Parkinson’s disease and apolipoprotein E: possible association with dementia but not age at onset. Genomics 2002; 79:458-461.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 47. Dubois B, Pillon B. Cognitive deficits in Parkinson’s disease. J Neurol 1997; 244:2-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 48. Ballard CG, Aarsland D, McKeith I, et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 2002; 59:1714-1720.[Abstract/Free Full Text]
  • 49. Cormack F, Aarsland D, Ballard CG, Trovée MJ. Pentagon drawing and neuropsychological performance in dementia with Lewy bodies, Alzheimer’s disease, Parkinson’s disease and Parkinson’s disease with dementia. Int J Geriatr Psychiatry 2004; 19:371-377.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 50. Ballard C, Holmes C, McKeith I, et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer’s disease. Am J Psychiatry 1999; 156:1039-1045.[Abstract/Free Full Text]
  • 51. Klatka LA, Louis ED, Schiffer RB. Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer’s disease and Parkinson’s disease comparison groups. Neurology 1996; 47:1148-1152.[Abstract/Free Full Text]
  • 52. Aarsland D, Ballard C, Larsen JP, McKeith I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia. Int J Geriatr Psychiatry 2001; 16:528-536.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 53. Boeve. Boeve F, Silber M, Ferman T. REM Sleep Behavior Disorder in Parkinson’s Disease and Dementia With Lewy Bodies. J Geriatr Psychiatry Neurol 2004; 17:146-157.[Abstract]
  • 54. Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occur-rence of depression in Parkinson’s disease: a community-based study. Arch Neurol 1996; 53:175-179.[Abstract/Free Full Text]
  • 55. Aarsland D, Ballard C, McKeith I, Perry RH, Larsen JP. Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson’s disease. J Neuropsychiatry Clin Neurosci 2001; 13:374-379.[Abstract/Free Full Text]
  • 56. Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA, Bannister P. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer’s and Parkinson’s diseases. J Neurol Neurosurg Psychiatry 1997; 62:243-252.[Abstract/Free Full Text]
  • 57. Burn DJ, Rowan EN, Minett T, et al. Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord 2003; 18:884-889.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 58. Ballard C, O’Brien J, Swann A, et al. One year follow-up of parkinsonism in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2000; 11:219-222.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 59. Poewe WH, Wenning GK. The natural history of Parkinson’s disease. Neurology 1996; 47:S146-S152.[Web of Science][Medline] [Order article via Infotrieve]
  • 60. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992; 305:673-678.
  • 61. Aarsland D, Ballard CG, Larsen JP, McKeith IG, O’Brien J, Perry R. Marked neuroleptic sensitivity in dementia with Lewy bodies and Parkinson’s disease. Nord J Psychiatry 2003; 57:94-94.
  • 62. Minett TS, Thomas A, Wilkinson LM, et al. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson’s disease with dementia. Int J Geriatr Psychiatry 2003; 18:988-993.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 63. Molloy S, O’Brien J, McKeith IG, Burn D. The motor response to levodopa (Ldopa) in dementia with Lewy bodies (DLB): a comparison to Parkinson’s disease (PD) with and without dementia. Paper presented at: 3rd International Workshop on Dementia With Lewy Bodies and Parkinson’s Disease Dementia (DLB/PDD); 2003; Newcastle Upon Tyne, United Kingdom.
  • 64. Merdes AR, Hansen LA, Jeste DV, et al. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology 2003; 60:1586-1590.[Abstract/Free Full Text]
  • 65. Ballard CG, Jacoby R, Del Ser T, et al. Neuropathological substrates of psychiatric symptoms in autopsy-confirmed prospectively studied patients with dementia with Lewy bodies (DLB). Am J Psychiatry 2004; 161:843-849.[Abstract/Free Full Text]
  • 66. Aarsland D, Litvan I, Salmon D, Galasko D, Wentzel-Larsen T, Larsen JP. Performance on the dementia rating scale in Parkinson’s disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2003; 74:1215-1220.[Abstract/Free Full Text]
  • 67. Noe E, Marder K, Bell KL, Jacobs DM, Manly JJ, Stern Y. Comparison of dementia with Lewy bodies to Alzheimer’s disease and Parkinson’s disease with dementia. Mov Disord 2004; 19:60-67.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 68. Horimoto Y, Matsumoto M, Nakazawa H, et al. Cognitive conditions of pathologically confirmed dementia with Lewy bodies and Parkinson’s disease with dementia. J Neurol Sci 2003; 216:105-108.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 69. Downes JJ, Priestley NM, Doran M, Ferran J, Ghadiali E, Cooper P. Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: a comparison with early and advanced Parkinson’s disease. Behav Neurol 1998; 11:173-183.[Web of Science][Medline] [Order article via Infotrieve]
  • 70. Cahn-Weiner DA, Williams K, Grace J, Tremont G, Westervelt H, Stern RA. Discrimination of dementia with Lewy bodies from Alzheimer disease and Parkinson disease using the clock drawing test. Cogn Behav Neurol 2003; 16:85-92.[Medline] [Order article via Infotrieve]
  • 71. Burn DJ, McKeith IG. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson’s disease. Mov Disord 2003; 18(suppl 6):S72-S79.
  • 72. Fernandez HH, Trieschmann ME, Burke MA, Friedman JH. Quetiapine for psychosis in Parkinson’s disease versus dementia with Lewy bodies. J Clin Psychiatry 2002; 63:513-515.[Web of Science][Medline] [Order article via Infotrieve]
  • 73. Rouleau I, Salmon DP, Butters N, et al. Quantitative and qualitative analyses of clock drawings in Alzheimer’s and Huntington’s disease. Brain Cogn. 1992; Jan; 18:70-87.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 74. Bourke J, Castleden CM, Stephen R, Dennis M. Short report: a comparison of clock and pentagon drawing in Alzheimer’s disease. Int J Geriatr Psychiatry 1995; 10:703-705.[CrossRef]
  • 75. Stern Y, Mayeux R, Sano M, et al. Predictors of disease course in patients with probable Alzheimer’s disease. Neurology 1987; 37:1649-1653.[Abstract/Free Full Text]

Journal of Geriatric Psychiatry and Neurology, Vol. 17, No. 3, 137-145 (2004)
DOI: 10.1177/0891988704267470
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 NeurologyHome page
H. Shimada, S. Hirano, H. Shinotoh, A. Aotsuka, K. Sato, N. Tanaka, T. Ota, M. Asahina, K. Fukushi, S. Kuwabara, et al.
Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET
Neurology, July 28, 2009; 73(4): 273 - 278.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. N. Gomperts, D. M. Rentz, E. Moran, J. A. Becker, J. J. Locascio, W. E. Klunk, C. A. Mathis, D. R. Elmaleh, T. Shoup, A. J. Fischman, et al.
Imaging amyloid deposition in Lewy body diseases
Neurology, September 16, 2008; 71(12): 903 - 910.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
J. J. Chen, D. P. Trombetta, and H. H. Fernandez
Palliative Management of Parkinson Disease: Focus on Nonmotor, Distressing Symptoms
Journal of Pharmacy Practice, August 1, 2008; 21(4): 262 - 272.
[Abstract] [PDF]

Home page
 NeurologyHome page
H. Braak and K. Del Tredici
Invited Article: Nervous system pathology in sporadic Parkinson disease
Neurology, May 13, 2008; 70(20): 1916 - 1925.
[Full Text] [PDF]

Home page
 PNHome page
I McKeith
Dementia with Lewy bodies and Parkinson's disease with dementia: where two worlds collide
Practical Neurology, November 1, 2007; 7(6): 374 - 382.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
D Aarsland, K Bronnick, U Ehrt, P P De Deyn, S Tekin, M Emre, and J L Cummings
Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress
J. Neurol. Neurosurg. Psychiatry, January 1, 2007; 78(1): 36 - 42.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. Ballard, I. Ziabreva, R. Perry, J. P. Larsen, J. O'Brien, I. McKeith, E. Perry, and D. Aarsland
Differences in neuropathologic characteristics across the Lewy body dementia spectrum
Neurology, December 12, 2006; 67(11): 1931 - 1934.
[Abstract] [Full Text] [PDF]

Home page
 AM J ALZHEIMERS DIS OTHER DEMENHome page
R. A. Armstrong
Laminar Distribution of {beta}-Amyloid Deposits in Dementia With Lewy Bodies and in Alzheimer's Disease
American Journal of Alzheimer's Disease and Other Dementias, May 1, 2006; 21(3): 175 - 181.
[Abstract] [PDF]

Home page
 Adv. Psychiatr. Treat.Home page
M. Samuel, I. Maidment, M. Boustani, and C. Fox
Clinical management of Parkinson's disease dementia: pitfalls and progress
Adv. Psychiatr. Treat., March 1, 2006; 12(2): 121 - 129.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
G. Fenelon, C. G. Goetz, and A. Karenberg
Hallucinations in Parkinson disease in the prelevodopa era
Neurology, January 10, 2006; 66(1): 93 - 98.
[Abstract] [Full Text] [PDF]

Home page
 Age AgeingHome page
J. Zaccai, C. McCracken, and C. Brayne
A systematic review of prevalence and incidence studies of dementia with Lewy bodies
Age Ageing, November 1, 2005; 34(6): 561 - 566.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
S Molloy, I G McKeith, J T O'Brien, and D J Burn
The role of levodopa in the management of dementia with Lewy bodies
J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1200 - 1203.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Aarsland, D.
Right arrow Articles by Halliday, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aarsland, D.
Right arrow Articles by Halliday, G.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement